OSE IMMUNOTHERAPEUTICS EUR0.20OSE IMMUNOTHERAPEUTICS EUR0.20OSE IMMUNOTHERAPEUTICS EUR0.20

OSE IMMUNOTHERAPEUTICS EUR0.20

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪144.76 M‬EUR
−1.18EUR
‪−23.00 M‬EUR
‪2.23 M‬EUR
‪15.52 M‬
Beta (1Y)
0.78

About OSE IMMUNOTHERAPEUTICS

CEO
Nicolas Poirier
Headquarters
Nantes
Employees (FY)
55
Founded
2004
ISIN
FR0012127173
FIGI
BBG00JHW6XN5
OSE Immunotherapeutics SA s is a biotechnology company, which engages in the research and development of pharmaceutical products. It focuses on developing and partnering therapies to control the immune system for immuno-oncology and immuno-inflammation. The company was founded by Dominique Constantini on November 17, 2004 and is headquartered in Nantes, France.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of 0RAD is 6.73 EUR — it has increased by 2.75% in the past 24 hours. Watch OSE IMMUNOTHERAPEUTICS EUR0.20 stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on LSE exchange OSE IMMUNOTHERAPEUTICS EUR0.20 stocks are traded under the ticker 0RAD.
OSE IMMUNOTHERAPEUTICS EUR0.20 is going to release the next earnings report on Sep 26, 2024. Keep track of upcoming events with our Earnings Calendar.
0RAD stock is 6.97% volatile and has beta coefficient of 0.78. Track OSE IMMUNOTHERAPEUTICS EUR0.20 stock price on the chart and check out the list of the most volatile stocks — is OSE IMMUNOTHERAPEUTICS EUR0.20 there?
Yes, you can track OSE IMMUNOTHERAPEUTICS EUR0.20 financials in yearly and quarterly reports right on TradingView.
0RAD stock has risen by 22.81% compared to the previous week, the month change is a 39.62% rise, over the last year OSE IMMUNOTHERAPEUTICS EUR0.20 has showed a 83.98% increase.
0RAD net income for the last quarter is ‪−11.14 M‬ EUR, while the quarter before that showed ‪−11.86 M‬ EUR of net income which accounts for 6.05% change. Track more OSE IMMUNOTHERAPEUTICS EUR0.20 financial stats to get the full picture.
Today OSE IMMUNOTHERAPEUTICS EUR0.20 has the market capitalization of ‪144.54 M‬, it has increased by 12.32% over the last week.
No, 0RAD doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, 0RAD shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade OSE IMMUNOTHERAPEUTICS EUR0.20 stock right from TradingView charts — choose your broker and connect to your account.
0RAD reached its all-time high on Mar 3, 2021 with the price of 13.65 EUR, and its all-time low was 2.73 EUR and was reached on Aug 29, 2023. View more price dynamics on 0RAD chart.
See other stocks reaching their highest and lowest prices.
As of May 9, 2024, the company has 55.00 employees. See our rating of the largest employees — is OSE IMMUNOTHERAPEUTICS EUR0.20 on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So OSE IMMUNOTHERAPEUTICS EUR0.20 technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating OSE IMMUNOTHERAPEUTICS EUR0.20 stock shows the buy signal. See more of OSE IMMUNOTHERAPEUTICS EUR0.20 technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on OSE IMMUNOTHERAPEUTICS EUR0.20 future price: according to them, 0RAD price has a max estimate of 10.00 EUR and a min estimate of 7.00 EUR. Watch 0RAD chart and read a more detailed OSE IMMUNOTHERAPEUTICS EUR0.20 stock forecast: see what analysts think of OSE IMMUNOTHERAPEUTICS EUR0.20 and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. OSE IMMUNOTHERAPEUTICS EUR0.20 EBITDA is ‪−28.83 M‬ EUR, and current EBITDA margin is ‪−1.30 K‬%. See more stats in OSE IMMUNOTHERAPEUTICS EUR0.20 financial statements.